Cerus | CERS - Ebitda





Ebitda Perubahan Tanggal
GRIFOLS EUR 473M 120M 2026-06
Haemonetics USD 111.41M 15.25M 2026-09
Neogen USD 41.6M 3.8M 2026-06
OraSure Technologies USD -17.7M 4.06M 2025-12
Plus Therapeutics USD -4.4M 2.94M 2025-09
Quidel USD 148M 18.7M 2026-09
STAAR Surgical USD 14.36M 5.64M 2026-09
Terumo JPY 116.67B 58.79B 2026-06